Comparison

SCDAA Clinical Trial Finder vs Moffitt PRIMA

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

SCDAA Clinical Trial Finder

Easily find clinical trials for sickle cell disease. Search by location, phase, or study type to connect patients, families, and caregivers with relevant research opportunities.

Highlights
  • Locate clinical trials
  • Sickle cell disease focus
  • Search by location
  • Filter by phase
  • Filter by study type
  • User-friendly interface
Features
Read full description

The Sickle Cell Disease Association of America's Clinical Trial Finder is a tool that easily allows patients, family members, or caregivers to locate clinical trials on sickle cell disease. The Trial Finder allows its users to find trials based on location, phase, or study type with an easy-to-use interference.

About

Moffitt PRIMA

Features
Read full description

PRIMA (Patient Research Information Management Application) is a multi-use application designed to raise awareness about breast cancer clinical trials at Moffitt Cancer Center. It helps patients stay organized with their treatments, and empower patients to communicate with their care team more effectively. • Simple and fast way to search breast cancer clinical trials currently enrolling at Moffitt Cancer Center with the ability to directly request more information about any listed trial. • Easily keep track of appointments and set reminders with the integrated calendar feature. • Secure messaging allows you to directly send your care team a message with any questions or concerns. • Learn more about clinical trials and research with expansive library of curated videos and online resources. • Improve patient quality of life by balancing treatment doses to be effective but not too toxic • Ability to log symptoms which is synced into your personal calendar and can be viewed and monitored by you and your care team.

Screenshots

SCDAA Clinical Trial Finder2 screens
Moffitt PRIMA4 screens

Verdict

The call

The clearest difference is update cadence: Moffitt PRIMA at monthly against SCDAA Clinical Trial Finder's every 40 months. On price, ads, in-app purchases and device support there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

UpkeepUpdate frequency

SCDAA Clinical Trial Finder ships an update every 40 months, Moffitt PRIMA monthly. The most recent releases landed on September 8, 2026 and September 9, 2026 respectively.

Scorecard1 real difference · 8 level
SCDAA Clinical Trial Finder versus Moffitt PRIMA: the parameters behind the verdict, then further details
ParameterSCDAA Clinical Trial FinderMoffitt PRIMA
PriceFreeFree
Rating4.5 (4 ratings) — better
Number of ratings4 — better
Update frequencyEvery 40 monthsMonthly — better
AdsNoNo
In-app purchasesNoNo
MonetizationFree
DevicesiPhone, iPad, iPodiPhone, iPad, iPod
Requires iOS13.0 — better13.4
Further details — not scored
Size58 MB24 MB
Age rating4+17+
DeveloperAutoWeb Technologies, LLCH. Lee Moffitt Cancer Center & Research Institute

In-app purchases

None

SCDAA Clinical Trial Finder

No in-app purchases

None

Moffitt PRIMA

No in-app purchases

Questions

Is SCDAA Clinical Trial Finder free?
SCDAA Clinical Trial Finder is free to download, with no in-app purchases.
Is Moffitt PRIMA free?
Moffitt PRIMA is free to download, with no in-app purchases.
Do SCDAA Clinical Trial Finder or Moffitt PRIMA have ads?
Neither SCDAA Clinical Trial Finder nor Moffitt PRIMA shows ads.
Which is updated more often, SCDAA Clinical Trial Finder or Moffitt PRIMA?
SCDAA Clinical Trial Finder ships an update every 40 months, and Moffitt PRIMA monthly. Most recently, SCDAA Clinical Trial Finder was updated on September 8, 2026 and Moffitt PRIMA on September 9, 2026.

Other comparisons